Authors: Gomeni, R Teneggi, V Iavarone, L Squassante, L Bye, A

Citation: R. Gomeni et al., Population pharmacokinetic-pharmacodynamic model of craving in an enforcedsmoking cessation population: Indirect response and probabilistic modeling, PHARM RES, 18(4), 2001, pp. 537-543

Authors: Ziviani, L Da Ros, L Squassante, L Milleri, S Cugola, M Iavarone, LE

Citation: L. Ziviani et al., The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects, BR J CL PH, 51(2), 2001, pp. 147-152

Authors: Kirby, S Falcoz, C Daniel, MJ Milleri, S Squassante, L Ziviani, L Ventresca, GP

Citation: S. Kirby et al., Salmeterol and fluticasone propionate given as a combination - Lack of systemic pharmacodynamic and pharmacokinetic interactions, EUR J CL PH, 56(11), 2001, pp. 781-791

Authors: Kunka, R Andrews, S Pimazzoni, M Callejas, S Ziviani, L Squassante, L Daley-Yates, PT

Citation: R. Kunka et al., Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs, RESP MED, 94, 2000, pp. S10-S16

Authors: Young, MMR Squassante, L Wemer, J van Merle, SP Dogterom, P Jonkman, JHG

Citation: Mmr. Young et al., Troglitazone has no effect on red cell mass or other erythropoietic parameters, EUR J CL PH, 55(2), 1999, pp. 101-104

Authors: Di Lorenzo, G Morici, G Drago, A Pellitteri, ME Mansueto, P Melluso, M Norrito, F Squassante, L Fasolo, A

Citation: G. Di Lorenzo et al., Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease, CLIN THER, 20(6), 1998, pp. 1130-1148